Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The best programs let players opt in without pressure, choose their preferred activities, and monitor progress in real time
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
Registro en PRSPERO: CRD42024565567
Statistical significance was determined using two-tailed Students t test through GraphPad Prism5 software unless otherwise mentioned
US$ 25.52
US$ 23.93
US$ 21.20
US$ 27.65
US$ 22.55
